Remote genetic evaluation for children with rare disorders
Official title: Virtual Platforms for Genetics Evaluation in the Medically Underserved
Run by Baylor College of Medicine · NCT05318222 · Data updated 2026-11-12
This study is testing a new online service to help kids with rare disorders along the Texas-Mexico border get faster genetic evaluations and better healthcare support.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 1 Day to 18 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Baylor College of Medicine Academic / other |
| Locations | 1 site (Edinburg, Texas) |
| Status | Recruiting |
| Started | June 1, 2022 |
| Main results expected | January 31, 2027 |
| Study ends | January 31, 2027 |
| Registry record updated | October 1, 2026 |
| Trial ID | NCT05318222 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are pediatric patients with undiagnosed rare genetic diseases residing in the Rio Grande Valley and El Paso in Texas.
✕Probably not a fit
Patients with known genetic diseases will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to improve genetic health for children with rare disorders living along the Texas-Mexico border by implementing a web-based service called Consultagene. The approach includes providing remote genetic evaluations and whole genome sequencing to facilitate rapid diagnoses and enhance medical decision-making. Additionally, the study focuses on educating healthcare providers to improve their genomic competency, thereby expediting referrals for pediatric patients with suspected rare diseases. The goal is to address the inadequate access to genetic services in this underserved population.
Why it matters
Potential benefit: If successful, this study could significantly enhance the diagnostic process and health outcomes for children with rare genetic disorders.
How similar studies have gone: While the approach of using virtual evaluations and genomic sequencing is innovative, similar studies have shown promise in improving access to genetic services in underserved populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Pediatric patients with undiagnosed rare genetic diseases residing in the Rio Grande Valley and El Paso in Texas Exclusion Criteria: Children with known genetic diseases
Where it's running
-
University of Texas Rio Grande Valley
Edinburg, Texas, United States Recruiting
Study contacts
- Principal investigator: Seema Lalani — Baylor College of Medicine
- Study coordinator: Seema Lalani, MD
- Email: seemal@bcm.edu
- Phone: 832-822-4280
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding brain development in congenital hypothyroidism: comparing affected children, healthy controls, and mild thyroid conditions
This study tests how brain development in children with congenital hypothyroidism compares to similar children without the condition and to kids with a mild thyroid finding.
-
Leopard: using multi-omics to boost genetic diagnosis for neurodevelopmental disorders
This study tests a multi-omics approach to find genetic explanations for neurodevelopmental disorders in people with moderate-to-severe intellectual disability.
-
Melillo Method for kids with behavior and learning challenges
This pilot test will see if the Melillo Method can be feasibly delivered in two Illinois schools to help kids aged 8 and up who have behavioral and learning difficulties.
-
Understanding how sensory brain signals vary in people with and without neurodevelopmental disorders
This study tests whether people with neurodevelopmental disorders show more variation in brain responses to sensory stimulation than people without these disorders.
-
Two-week intensive brain-focused therapy program for children with neurodevelopmental and chromosomal conditions
This program will try a two-week, individualized multimodal neurorehabilitation approach for children about 4–12 years old with neurodevelopmental or chromosomal conditions to see if it improves attention, motor skills, communication, and daily functioning.
-
Social cognition testing for 8–16-year-olds with autism, ADHD, or atypical development
This project will test a multidimensional social-cognition battery in French-speaking 8–16-year-olds with autism, ADHD, or atypical neurodevelopment to see if it better identifies social processing differences.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.